Skip to content

Clinical trials

Gastrointestinal Stromal Tumors trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Country / region: China Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20092
20101
20112
20121
20132
20143
20151
20163
20171
20185
20193
20207
20216
20227
20234
20242
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status19
Completed18
Recruiting16
Active, not recruiting4
Not yet recruiting3
Terminated3
No longer available1
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
First Affiliated Hospital, Sun Yat-Sen University4
Peking University4
Huazhong University of Science and Technology3
Peking University People's Hospital3
RenJi Hospital3
Xinhua Zhang, MD3
Bayer2
CStone Pharmaceuticals2
First Affiliated Hospital Xi'an Jiaotong University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors66
Colorectal Neoplasms5
Gastrointestinal Neoplasms5
Stomach Neoplasms4
Leiomyoma3
Neoplasm Metastasis3
Biliary Tract Neoplasms2
Esophageal Neoplasms2
Esophageal Squamous Cell Carcinoma2
Neoplasm, Residual2

Trials

Showing 76 to 66 of 66. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.